Hemiplegic cerebral palsy: role of repeat botulinum toxin A injections as an adjunct to occupational therapy
Janice E Brunstrom
Correspondence Washington University School of Medicine, Department of Pediatric Neurology, 660 South Euclid Avenue, Box 8111, St Louis, MO 63110-1093, USA
Email brunstromj@neuro.wustl.edu
This article has no abstract so we have provided the first paragraph of the full text.
Upper-limb impairments contribute considerably to disability in many children with CP and have a negative effect on independence, education, future employment, self esteem, and participation in society.1, 2 BTX-A has gained popularity among clinicians as a useful tool for reducing spasticity and improving upper-limb range of motion and function in patients with CP, despite a lack of well controlled trials to establish its efficacy.1, 2, 3
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.